Login / Signup

Rapid onset type 1 diabetes associated with the programmed cell death-1 inhibitor pembrolizumab.

Veronica BoyleTim CundyRichard Cutfield
Published in: Internal medicine journal (2020)
Keyphrases
  • type diabetes
  • glycemic control
  • advanced non small cell lung cancer
  • cardiovascular disease
  • insulin resistance
  • epidermal growth factor receptor
  • sensitive detection